About this site
Why “life coach”?
Because a conversation about progress needs room for a life. That is the ambition behind the name, without claiming a professional role.
The title’s boundaries
GLP-1 Life Coach is the title of my notebook on published research about semaglutide. It is an editorial site, not a coaching business or a healthcare practice. Sessions, clinical assessments, prescriptions and products are unavailable here. Nothing here is medical advice.
For me, the name opens a question: what counts as progress when a conversation concerns someone’s life? Letting a weight figure supply the entire answer feels remarkably incurious to me. A fuller account can give duration, tolerability and health outcomes space of their own, without setting a score for the person at the center of it.
There is no professional title hiding in the word “coach.” It names the site’s interest in follow-through. The boundary is straightforward: reading and discussion happen here; individual care happens elsewhere.
Why semaglutide?
The STEP 1 weight result is substantial enough to deserve a close look on its own. Then SELECT asks about cardiovascular events in people with established cardiovascular disease and overweight or obesity without diabetes, and FLOW asks about kidney-disease events in people with type 2 diabetes and chronic kidney disease.
That range widened my sense of what a progress report could contain. My curiosity has shifted toward the breadth of a treatment’s effects, its population and its span of follow-up. I’m equally interested in the burdens that accompany a benefit. Those interests fit together comfortably; enthusiasm can survive a full account of the tradeoffs.
The progress cards begin with weight and duration. The reading list has the published sources behind the discussion. I hope the result feels like a conversation with enough time to finish a thought, rather than a pep talk rushing toward a conclusion.